secwatch.observer — SEC 8-K summary
======================================

Issuer:     JUPITER NEUROSCIENCES, INC. (JUNS)
CIK:        0001679628
Form:       8-K
Filed at:   2026-07-27T13:00:41+00:00
Accession:  0001493152-26-034724
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jupiter Neurosciences shareholders approve reverse stock split (1:10-1:100) and 5.25M share equity plan increase
--------------------------------------------------------------------------------

- Shareholders approved reverse stock split at ratio between 1:10 and 1:100, with board discretion on timing and ratio.
- Equity incentive plan amended to increase authorized shares by 5,250,000 shares.
- All seven director nominees elected; Cherry Bekaert ratified as auditor for FY2026.
- Under SEPA with Yorkville, ~$1.5M convertible notes outstanding; ~12.5M shares issued for ~$4.1M net proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1679628/000149315226034724/0001493152-26-034724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1679628/000149315226034724/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-034724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer